You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Strong Phase Ib results elevate Camurus in the global GLP-1 race
Text:
Tommie Anderberg | [email protected]
In a market dominated by GLP-1 drugs from Novo Nordisk and Eli Lilly, Camurus is now taking a step forward with its long-acting semaglutide formulation CAM2056 – a monthly injection that provides significantly better...